Gentisic Acid
CAS 490-79-9
Gentisic Acid (CAS 490-79-9) is a pharmaceutical compound with 7 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | AC50 | 28935.29117647059 nM | 34 | - |
| - | Ki | 23100 nM | 7 | - |
| - | IC50 | 43842.524 nM | 4 | - |
| - | Potency | 79747.93333333333 nM | 3 | - |
| - | EC50 | 29.2 nM | 1 | - |
| Carbonic anhydrase 2 Enzyme |
Ki | 5.39 | - | Homo sapiens |
| Carbonic anhydrase 1 Enzyme |
Ki | 5.38 | - | Homo sapiens |
| Carbonic anhydrase 9 Enzyme |
Ki | 5.18 | - | Homo sapiens |
| Carbonic anhydrase 12 Enzyme |
Ki | 5.14 | - | Homo sapiens |
| Arachidonate 5-lipoxygenase Enzyme |
IC50 | 4.12 | - | Homo sapiens |
| Carbonic anhydrase 7 Enzyme |
Ki | 4.17 | - | Homo sapiens |
| Carbonic anhydrase 14 Enzyme |
Ki | 4.17 | - | Homo sapiens |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| GENTISIC ACID | 1368641 | SU | MTHSPL |
| gentisic acid | 1368641 | PIN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Gentisic Acid used for in pharmaceutical contexts?
Gentisic Acid (CAS 490-79-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Gentisic Acid?
No adverse-event association or SIDER side-effect rows are rendered for Gentisic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Gentisic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Gentisic Acid with EU status "permitted".
What clinical phase is Gentisic Acid in?
No phase 1-4 clinical development badge is rendered for Gentisic Acid because the matched compound identifier rows do not contain a max-phase value.
What bioactivity targets are documented for Gentisic Acid?
Gentisic Acid has 12 bioactivity rows in this page query. Rendered target entries include Carbonic anhydrase 2, Carbonic anhydrase 1, Carbonic anhydrase 9, Carbonic anhydrase 12, Arachidonate 5-lipoxygenase.